How many clinical trials are in each phase?

About half the 461,000 clinical trials registered on ClinicalTrials.gov as of September 2026, some 237,000, have no phase: phases describe drug trials, and these test devices, surgery, behavior or diet. Among drug trials, Phase 2 (does it work, and at what dose?) is the most common with about 66,000. Phase 1 tests safety in a few people, Phase 3 compares a treatment with the usual care in many, and Phase 4 follows a drug after approval.

The interactive chart needs JavaScript. The numbers are in the table below.

The value axis starts at zero. Hover, tap or use the arrow keys to read exact values.

Save a simple drawing of this chart for slides, essays or posts, with its question, source, date and a link back to this page. Please keep the credit.

Download image

Key facts

Measure: Clinical trials (all years). Written from the data below.

  • No phase (devices, behavior, etc.) has the highest figure, 238,806, followed by Phase 2 (65,808) and Phase 1 (48,838).
  • Early Phase 1 has the lowest figure, 6,502, followed by Phase 2/3 (7,623) and Phase 1/2 (17,134).
  • The highest is 37 times the lowest.

Source and date

Data as of
Published

Citation

Chartly. “How many clinical trials are in each phase?” Chart. Data: ClinicalTrials.gov (U.S. National Library of Medicine), counted with its API v2, https://clinicaltrials.gov/data-api/api (data as of October 14, 2026). https://chart.ly/charts/clinical-trials-by-phase (accessed October 15, 2026).

Free for your article, blog or class page: paste this code where the chart should go. It shows the interactive chart with its source and a small “Chart by Chartly” credit, and stays up to date when the data changes.

The file has the numbers in this table, with the source, license and date. Please credit the source and Chartly.

Phase Clinical trials (all years)
Early Phase 1 6,502
Phase 1 48,838
Phase 1/2 17,134
Phase 2 65,808
Phase 2/3 7,623
Phase 3 42,394
Phase 4 35,947
No phase (devices, behavior, etc.) 238,806

Get new charts weekly

One email a week with the newest charts and their key numbers. No account needed.